Public health experts are raising new concerns that achieving herd immunity in the United States looks increasingly unlikely. Although this doesn’t reduce the urgent need to get as many people vaccinated as possible, it does mean that we may need to begin planning for how we will live with COVID-19 as an ... READ MORE >
FDA
5 things to know in life sciences: Week of April 26
Getting people vaccinated can be a public health challenge. Getting them to come back for a second dose at the right time can be even more difficult. This week we highlight why people may be skipping their second COVID-19 dose and how challenging getting that second dose can be even for people motivated ... READ MORE >
5 things to know in life sciences: Week of April 19
This week we look at comments from acting Food and Drug Administration commissioner Janet Woodcock on perceptions that the agency is getting tougher on drug companies during the approval process. We also highlight new uses of CRISPR to control gene expression, venture funds focused on life sciences, newly ... READ MORE >
5 things to know in life sciences: Week of April 5
As the months of 2021 tick by, the percentage of Americans vaccinated is rapidly increasing. This offers the hope of a return to more normal life but also raises new questions, including whether companies can mandate vaccines or how we track the virus. We also look at the lack of diversity on the boards ... READ MORE >
5 things to know in life sciences: Week of March 22
In this week’s life sciences roundup: the AstraZeneca-Oxford COVID-19 vaccine has faced challenging headwinds in the past week as several European Union countries paused distribution pending additional information from the European Medicines Agency, and as the National Institute of Allergy and Infectious ... READ MORE >
Coronavirus disrupts the pipeline for new drugs and medical devices
On March 10, a day before the World Health Organization declared the coronavirus outbreak a pandemic, the Food and Drug Administration announced that it was postponing foreign inspections through April. This increases the risk that some drug and device companies will run into issues obtaining approval ... READ MORE >